Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Proceedings of the Association for Information Science and Technology. Association for Information Science and Technology|December 13, 2021
Public Engagement with Science via Social Media: A Case of Communicating the Pandemic on TwitterEmma Knox, Noriko Hara
International Journal of Language & Communication Disorders|February 6, 2003
Bullying risks of 11-year-old children with specific language impairment (SLI): does school placement matter?Emma Knox, Gina Conti-Ramsden
International Journal of Language & Communication Disorders|May 16, 2002
Different school placements following language unit attendance: which factors affect language outcome?Gina Conti-Ramsden, Nicola Botting, Emma Knox, et al.
International Journal of Language & Communication Disorders|July 9, 2008
Specific language impairment and school outcomes. II: Educational context, student satisfaction, and post-compulsory progressKevin Durkin, Zoë Simkin, Emma Knox, et al.
International Journal of Language & Communication Disorders|July 9, 2008
Specific language impairment and school outcomes. I: identifying and explaining variability at the end of compulsory educationGina Conti-Ramsden, Kevin Durkin, Zoë Simkin, et al.
The Lancet. Psychiatry|October 17, 2018
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialBill Deakin, John Suckling, Thomas R E Barnes, et al.
The Journal of Antimicrobial Chemotherapy|June 16, 2026
A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infectionSaye H Khoo, Richard FitzGerald, Christopher J Edwards, et al.
The Lancet. Infectious Diseases|October 22, 2022
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trialSaye H Khoo, Richard FitzGerald, Geoffrey Saunders, et al.
Nature Communications|November 26, 2022
Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trialI'ah Donovan-Banfield, Rebekah Penrice-Randal, Hannah Goldswain, et al.
Pageof 1